Donor T-cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem cell transplant.

@article{Taimur2014DonorTC,
  title={Donor T-cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem cell transplant.},
  author={Sarah Taimur and Medhat Askar and R Sobecks and Lisa R. Rybicki and Ilka Warshawsky and S Mossad},
  journal={Transplant infectious disease : an official journal of the Transplantation Society},
  year={2014},
  volume={16 1},
  pages={61-6}
}
BACKGROUND Cytomegalovirus (CMV) is a common infection after myeloablative allogeneic hematopoietic stem cell transplant (M-alloHSCT). Achievement of complete donor T-cell chimerism (CDC-T) post transplant is a measure of immune reconstitution. We investigated the association between CDC-T post M-alloHSCT and the incidence of CMV viremia. METHODS We… CONTINUE READING